glp-1 gip and glucagon Potential of a glucagon‐like peptide‐1 receptor/glucose‐dependent insulinotropic polypeptide receptor/glucagon receptor triagonist for the treatment of obesity type 2 diabetes - Araki - 2022 - Journal of Diabetes Investigation LY3437943, a novel triple glucagon,

Should people with a history of stomach problems avoid GLP-1

A faster metabolism allows the body to burn calories efficiently

And so as a result because you dont have to the digestive system doesnt have to be so responsive to the messages of the vagus nerve, which if theyre design, if our own hormones are designed like a motion detector, I would argue its like theyre experiencing a stampede in front of the motion detector, Like all day long and and even all night long

Increasing (or decreasing) ghrelin may or may not be beneficial to ones health

The side effects of compounded GLP-1 therapy are typically brief and improve with time

doi: 10.1113/jphysiol.2002.033811 55 ZhangJJinHZhangWDingCOKeeffeSYeMet al